反応 #4144114
関連文献 (1)
openreactiondata ↗doi:10.1039/C8SC04228D
反応条件: temp:0.00; pressure:0.00; stir:
ソース ID: ord-2f5e25a0b9ba42ed81655a3a39126911表示可能な構造データがありません
C(CO)C(CCO)N製品情報
3-aminopentane-1,5-diol (CAS 1117-23-3) product identity, structure identifiers and related reaction data for chemical intermediate research and sourcing review.
想定用途
専門的研究・工業用途限定
データベース ID 21117805
安全上の注意
For professional research and industrial use only. Review the supplier safety data sheet before handling.
合成データ
12 反応 · 12 文献
反応条件: temp:0.00; pressure:0.00; stir:
ソース ID: ord-2f5e25a0b9ba42ed81655a3a39126911反応条件: temp:0.00; pressure:0.00; stir:
ソース ID: ord-2f5e25a0b9ba42ed81655a3a39126911反応条件: temp:0.00; pressure:0.00; stir:
ソース ID: ord-2f5e25a0b9ba42ed81655a3a39126911反応条件: temp:45.01; pressure:0.00; stir:; See reaction.notes.procedure_details.
実験手順: To a solution of 3-aminopentane-1,5-diol (2.38 g, 20 mmol) (Helv. Chim. Acta 1964, 47(8), 2145-2153) and triethylamine (4 ml), in dichloromethane (30 ml), was slowly added, at 0° C., a solution of [2,1,3]-benzoxadiazole-5-carboxylic acid chloride (1.82 g, 10 mmol), in dichloromethane (20 ml), and the mixture stirred for 1 h. A mixture of methanol (30 ml) and 4N potassium carbonate solution (20 ml) was added and stirred for 3 h. The mixture was evaporated onto silica gel and purified by silica gel chromatography eluting with ethyl acetate/chloroform/methanol (60:30:10) to give, after crystallization from dichloromethane/ethyl acetate/diethyl ether, N-(1,5-dihydroxypentan-3-yl)-[2,1,3]-benzoxadiazole-5-carboxamide as a white solid (Mp: 87-88° C.). N-(1,5-Dihydroxypentan-3-yl)-[2,1,3]-benzoxadiazole-5-carboxamide (0.5 g, 1.9 mmol), suspended in chloroform (20 ml), was warmed to 45° C. and periodinane (Dess Martin reagent; 1.6 g) added and stirred for 1 h. The reaction mixture was evaporated onto silica gel and purified by chromatography, eluting with ethyl acetate/chloroform (60:40) to give N-(2-hydroxytetrahydro-2H-pyran-4-yl)-[2,1,3]-benzoxadiazole-5-carboxamide (0.12 g) as a white solid after trituration with diethyl ether and as the less polar of two components (Rf: 0.55). Mp=91-92° C., 1H NMR (300 MHz, CDCl3) δ 8.22 (s, 1H); 7.96-7.81 (m, 2H); 7.10-7.00 and 6.40-6.05 (m, 2H); 4.65-4.40 (m, 1H); 4.15-3.70 (m, 2H) and 2.15-0.60 ppm (m, 4H). was added The mixture was evaporated onto silica gel purified by silica gel chromatography eluting with ethyl acetate/chloroform/methanol (60:30:10) to give after crystallization from dichloromethane/ethyl acetate/diethyl ether, N-(1,5-dihydroxypentan-3-yl)-[2,1,3]-benzoxadiazole-5-carboxamide as a white solid (Mp: 87-88° C.) stirred for 1 h The reaction mixture was evaporated onto silica gel purified by chromatography eluting with ethyl acetate/chloroform (60:40)
ソース ID: ord-5bcd8f5b995649dbbf183835db538685反応条件: temp:45.01; pressure:0.00; stir:; See reaction.notes.procedure_details.
実験手順: To a solution of 3-aminopentane-1,5-diol (2.38 g, 20 mmol) (Helv. Chim. Acta 1964, 47(8), 2145-2153) and triethylamine (4 ml), in dichloromethane (30 ml), was slowly added, at 0° C., a solution of [2,1,3]-benzoxadiazole-5-carboxylic acid chloride (1.82 g, 10 mmol), in dichloromethane (20 ml), and the mixture stirred for 1 h. A mixture of methanol (30 ml) and 4N potassium carbonate solution (20 ml) was added and stirred for 3 h. The mixture was evaporated onto silica gel and purified by silica gel chromatography eluting with ethyl acetate/chloroform/methanol (60:30:10) to give, after crystallization from dichloromethane/ethyl acetate/diethyl ether, N-(1,5-dihydroxypentan-3-yl)-[2,1,3]-benzoxadiazole-5-carboxamide as a white solid (Mp: 87-88° C.). N-(1,5-Dihydroxypentan-3-yl)-[2,1,3]-benzoxadiazole-5-carboxamide (0.5 g, 1.9 mmol), suspended in chloroform (20 ml), was warmed to 45° C. and periodinane (Dess Martin reagent; 1.6 g) added and stirred for 1 h. The reaction mixture was evaporated onto silica gel and purified by chromatography, eluting with ethyl acetate/chloroform (60:40) to give N-(2-hydroxytetrahydro-2H-pyran-4-yl)-[2,1,3]-benzoxadiazole-5-carboxamide (0.12 g) as a white solid after trituration with diethyl ether and as the less polar of two components (Rf: 0.55). Mp=91-92° C., 1H NMR (300 MHz, CDCl3) δ 8.22 (s, 1H); 7.96-7.81 (m, 2H); 7.10-7.00 and 6.40-6.05 (m, 2H); 4.65-4.40 (m, 1H); 4.15-3.70 (m, 2H) and 2.15-0.60 ppm (m, 4H). was added The mixture was evaporated onto silica gel purified by silica gel chromatography eluting with ethyl acetate/chloroform/methanol (60:30:10) to give after crystallization from dichloromethane/ethyl acetate/diethyl ether, N-(1,5-dihydroxypentan-3-yl)-[2,1,3]-benzoxadiazole-5-carboxamide as a white solid (Mp: 87-88° C.) stirred for 1 h The reaction mixture was evaporated onto silica gel purified by chromatography eluting with ethyl acetate/chloroform (60:40)
ソース ID: ord-37dc63bd1aa046ad89d5a9ff8e01f8f5反応条件: temp:45.01; pressure:0.00; stir:; See reaction.notes.procedure_details.
実験手順: To a solution of 3-aminopentane-1,5-diol (2.38 g, 20 mmol) (Helv. Chim. Acta 1964, 47(8), 2145-2153) and triethylamine (4 ml), in dichloromethane (30 ml), was slowly added, at 0° C., a solution of [2,1,3]-benzoxadiazole-5-carboxylic acid chloride (1.82 g, 10 mmol), in dichloromethane (20 ml), and the mixture stirred for 1 h. A mixture of methanol (30 ml) and 4N potassium carbonate solution (20 ml) was added and stirred for 3 h. The mixture was evaporated onto silica gel and purified by silica gel chromatography eluting with ethyl acetate/chloroform/methanol (60:30:10) to give, after crystallization from dichloromethane/ethyl acetate/diethyl ether, N-(1,5-dihydroxypentan-3-yl)-[2,1,3]-benzoxadiazole-5-carboxamide as a white solid (Mp: 87-88° C.). N-(1,5-Dihydroxypentan-3-yl)-[2,1,3]-benzoxadiazole-5-carboxamide (0.5 g, 1.9 mmol), suspended in chloroform (20 ml), was warmed to 45° C. and periodinane (Dess Martin reagent; 1.6 g) added and stirred for 1 h. The reaction mixture was evaporated onto silica gel and purified by chromatography, eluting with ethyl acetate/chloroform (60:40) to give N-(2-hydroxytetrahydro-2H-pyran-4-yl)-[2,1,3]-benzoxadiazole-5-carboxamide (0.12 g) as a white solid after trituration with diethyl ether and as the less polar of two components (Rf: 0.55). Mp=91-92° C., 1H NMR (300 MHz, CDCl3) δ 8.22 (s, 1H); 7.96-7.81 (m, 2H); 7.10-7.00 and 6.40-6.05 (m, 2H); 4.65-4.40 (m, 1H); 4.15-3.70 (m, 2H) and 2.15-0.60 ppm (m, 4H). was added The mixture was evaporated onto silica gel purified by silica gel chromatography eluting with ethyl acetate/chloroform/methanol (60:30:10) to give after crystallization from dichloromethane/ethyl acetate/diethyl ether, N-(1,5-dihydroxypentan-3-yl)-[2,1,3]-benzoxadiazole-5-carboxamide as a white solid (Mp: 87-88° C.) stirred for 1 h The reaction mixture was evaporated onto silica gel purified by chromatography eluting with ethyl acetate/chloroform (60:40)
ソース ID: ord-37dc63bd1aa046ad89d5a9ff8e01f8f5反応条件: temp:45.01; pressure:0.00; stir:; See reaction.notes.procedure_details.
実験手順: To a solution of 3-aminopentane-1,5-diol (2.38 g, 20 mmol) (Helv. Chim. Acta 1964, 47(8), 2145-2153) and triethylamine (4 ml), in dichloromethane (30 ml), was slowly added, at 0° C., a solution of [2,1,3]-benzoxadiazole-5-carboxylic acid chloride (1.82 g, 10 mmol), in dichloromethane (20 ml), and the mixture stirred for 1 h. A mixture of methanol (30 ml) and 4N potassium carbonate solution (20 ml) was added and stirred for 3 h. The mixture was evaporated onto silica gel and purified by silica gel chromatography eluting with ethyl acetate/chloroform/methanol (60:30:10) to give, after crystallization from dichloromethane/ethyl acetate/diethyl ether, N-(1,5-dihydroxypentan-3-yl)-[2,1,3]-benzoxadiazole-5-carboxamide as a white solid (Mp: 87-88° C.). N-(1,5-Dihydroxypentan-3-yl)-[2,1,3]-benzoxadiazole-5-carboxamide (0.5 g, 1.9 mmol), suspended in chloroform (20 ml), was warmed to 45° C. and periodinane (Dess Martin reagent; 1.6 g) added and stirred for 1 h. The reaction mixture was evaporated onto silica gel and purified by chromatography, eluting with ethyl acetate/chloroform (60:40) to give N-(2-hydroxytetrahydro-2H-pyran-4-yl)-[2,1,3]-benzoxadiazole-5-carboxamide (0.12 g) as a white solid after trituration with diethyl ether and as the less polar of two components (Rf: 0.55). Mp=91-92° C., 1H NMR (300 MHz, CDCl3) δ 8.22 (s, 1H); 7.96-7.81 (m, 2H); 7.10-7.00 and 6.40-6.05 (m, 2H); 4.65-4.40 (m, 1H); 4.15-3.70 (m, 2H) and 2.15-0.60 ppm (m, 4H). was added The mixture was evaporated onto silica gel purified by silica gel chromatography eluting with ethyl acetate/chloroform/methanol (60:30:10) to give after crystallization from dichloromethane/ethyl acetate/diethyl ether, N-(1,5-dihydroxypentan-3-yl)-[2,1,3]-benzoxadiazole-5-carboxamide as a white solid (Mp: 87-88° C.) stirred for 1 h The reaction mixture was evaporated onto silica gel purified by chromatography eluting with ethyl acetate/chloroform (60:40)
ソース ID: ord-5bcd8f5b995649dbbf183835db538685反応条件: temp:45.01; pressure:0.00; stir:; See reaction.notes.procedure_details.
実験手順: To a solution of 3-aminopentane-1,5-diol (2.38 g, 20 mmol) (Helv.Chim.Acta 1964, 47(8), 2145-2153) and triethylamine (4 ml), in dichloromethane (30 ml), was slowly added, at 0° C., a solution of [2,1,3]-benzoxadiazole-5-carboxylic acid chloride (1.82 g, 10 mmol), in dichloromethane (20 ml), and the mixture stirred for 1 h. A mixture of methanol (30 ml) and 4N potassium carbonate solution (20 ml) was added and stirred for 3 h. The mixture was evaporated onto silica gel and purified by silica gel chromatography eluting with ethyl acetate/chloroform/methanol (60:30:10) to give, after crystallization from dichloromethane/ethyl acetate/diethyl ether, N-(1,5-dihydroxypentan-3-yl)-[2,1,3]-benzoxadiazole-5-carboxamide as a white solid (Mp: 87-88° C.). N-(1,5-Dihydroxypentan-3-yl)-[2,1,3]-benzoxadiazole-5-carboxamide (0.5 g, 1.9 mmol), suspended in chloroform (20 ml), was warmed to 45° C. and periodinane (Dess Martin reagent; 1.6 g) added and stirred for 1 h. The reaction mixture was evaporated onto silica gel and purified by chromatography, eluting with ethyl acetate/chloroform (60:40) to give N-(2-hydroxytetrahydro-2H-pyran-4-yl)-[2,1,3]-benzoxadiazole-5-carboxamide (0.12 g) as a white solid after trituration with diethyl ether and as the less polar of two components (Rf: 0.55). Mp=91-92° C., 1H NMR (300 MHz, CDCl3) δ 8.22 (s, 1H); 7.96-7.81 (m, 2H); 7.10-7.00 and 6.40-6.05 (m, 2H); 4.65-4.40 (m, 1H); 4.15-3.70 (m, 2H) and 2.15-0.60 ppm (m, 4H). was added The mixture was evaporated onto silica gel purified by silica gel chromatography eluting with ethyl acetate/chloroform/methanol (60:30:10) to give after crystallization from dichloromethane/ethyl acetate/diethyl ether, N-(1,5-dihydroxypentan-3-yl)-[2,1,3]-benzoxadiazole-5-carboxamide as a white solid (Mp: 87-88° C.) stirred for 1 h The reaction mixture was evaporated onto silica gel purified by chromatography eluting with ethyl acetate/chloroform (60:40)
ソース ID: ord-9203634cb5144fd3856537902929d3b7反応条件: temp:0.00; pressure:0.00; stir:; See reaction.notes.procedure_details.
実験手順: The compound was prepared from [4-amino-2-[1-(3-chloro-propane-1-sulfonyl)-piperidin-4-ylamino]-pyrimidin-5-yl]-(2,3-difluoro-6-methoxy-phenyl)-methanone (Example 226) and 3-amino-pentane-1,5-diol (prepared from the methyl oxime of diethyl 1,3-acetonedicarboxylate, Aldrich, by reduction with lithium aluminum hydride in diethyl ether) in an analogous manner as described in Example 227. HR-MS (ES, m/z) calculated for C25H37N6O6SF2[(M+H)+] 587.2458, observed 587.2464.
ソース ID: ord-e87775e133fb4e2db224542f51f86fbd反応条件: temp:0.00; pressure:0.00; stir:; See reaction.notes.procedure_details.
実験手順: The compound was prepared from [4-amino-2-[1-(3-chloro-propane-1-sulfonyl)-piperidin-4-ylamino]-pyrimidin-5-yl]-(2,3-difluoro-6-methoxy-phenyl)-methanone (Example 226) and 3-amino-pentane-1,5-diol (prepared from the methyl oxime of diethyl 1,3-acetonedicarboxylate, Aldrich, by reduction with lithium aluminum hydride in diethyl ether) in an analogous manner as described in Example 227. HR-MS (ES, m/z) calculated for C25H37N6O6SF2 [(M+H)+] 587.2458, observed 587.2464.
ソース ID: ord-4f04fa8e31bd4d4b8f03732167c24bb8反応条件: temp:45.01; pressure:0.00; stir:; See reaction.notes.procedure_details.
実験手順: To a solution of 3-aminopentane-1,5-diol (2.38 g, 20 mmol) (Helv. Chim. Acta 1964, 47(8), 2145-2153) and triethylamine (4 ml), in dichloromethane (30 ml), was slowly added, at 0° C., a solution of [2,1,3]-benzoxadiazole-5-carboxylic acid chloride (1.82 g, 10 mmol), in dichloromethane (20 ml), and the mixture stirred for 1 h. A mixture of methanol (30 ml) and 4N potassium carbonate solution (20 ml) was added and stirred for 3 h. The mixture was evaporated onto silica gel and purified by silica gel chromatography eluting with ethyl acetate/chloroform/methanol (60:30:10) to give, after crystallization from dichloromethane/ethyl acetate/diethyl ether, N-(1,5-dihydroxypentan-3-yl)-[2,1,3]-benzoxadiazole-5-carboxamide as a white solid (Mp: 87-88° C.). N-(1,5-Dihydroxypentan-3-yl)-[2,1,3]-benzoxadiazole-5-carboxamide (0.5 g, 1.9 mmol), suspended in chloroform (20 ml), was warmed to 45° C. and periodinane (Dess Martin reagent; 1.6 g) added and stirred for 1 h. The reaction mixture was evaporated onto silica gel and purified by chromatography, eluting with ethyl acetate/chloroform (60:40) to give N-(2-hydroxytetrahydro-2H-pyran-4-yl)-[2,1,3]-benzoxadiazole-5-carboxamide (0.12 g) as a white solid after trituration with diethyl ether and as the less polar of two components (Rf: 0.55). Mp=91-92° C., 1H NMR (300 MHz, CDCl3) δ 8.22 (s, 1H); 7.96-7.81 (m, 2H); 7.10-7.00 and 6.40-6.05 (m, 2H); 4.65-4.40 (m, 1H); 4.15-3.70 (m, 2H) and 2.15-0.60 ppm (m, 4H). was added The mixture was evaporated onto silica gel purified by silica gel chromatography eluting with ethyl acetate/chloroform/methanol (60:30:10) to give after crystallization from dichloromethane/ethyl acetate/diethyl ether, N-(1,5-dihydroxypentan-3-yl)-[2,1,3]-benzoxadiazole-5-carboxamide as a white solid (Mp: 87-88° C.) stirred for 1 h The reaction mixture was evaporated onto silica gel purified by chromatography eluting with ethyl acetate/chloroform (60:40)
ソース ID: ord-37dc63bd1aa046ad89d5a9ff8e01f8f5反応条件: temp:45.01; pressure:0.00; stir:; See reaction.notes.procedure_details.
実験手順: To a solution of 3-aminopentane-1,5-diol (2.38 g, 20 mmol) (Helv. Chim. Acta 1964, 47(8), 2145-2153) and triethylamine (4 ml), in dichloromethane (30 ml), was slowly added, at 0° C., a solution of [2,1,3]-benzoxadiazole-5-carboxylic acid chloride (1.82 g, 10 mmol), in dichloromethane (20 ml), and the mixture stirred for 1 h. A mixture of methanol (30 ml) and 4N potassium carbonate solution (20 ml) was added and stirred for 3 h. The mixture was evaporated onto silica gel and purified by silica gel chromatography eluting with ethyl acetate/chloroform/methanol (60:30:10) to give, after crystallization from dichloromethane/ethyl acetate/diethyl ether, N-(1,5-dihydroxypentan-3-yl)-[2,1,3]-benzoxadiazole-5-carboxamide as a white solid (Mp: 87-88° C.). N-(1,5-Dihydroxypentan-3-yl)-[2,1,3]-benzoxadiazole-5-carboxamide (0.5 g, 1.9 mmol), suspended in chloroform (20 ml), was warmed to 45° C. and periodinane (Dess Martin reagent; 1.6 g) added and stirred for 1 h. The reaction mixture was evaporated onto silica gel and purified by chromatography, eluting with ethyl acetate/chloroform (60:40) to give N-(2-hydroxytetrahydro-2H-pyran-4-yl)-[2,1,3]-benzoxadiazole-5-carboxamide (0.12 g) as a white solid after trituration with diethyl ether and as the less polar of two components (Rf: 0.55). Mp=91-92° C., 1H NMR (300 MHz, CDCl3) δ 8.22 (s, 1H); 7.96-7.81 (m, 2H); 7.10-7.00 and 6.40-6.05 (m, 2H); 4.65-4.40 (m, 1H); 4.15-3.70 (m, 2H) and 2.15-0.60 ppm (m, 4H). was added The mixture was evaporated onto silica gel purified by silica gel chromatography eluting with ethyl acetate/chloroform/methanol (60:30:10) to give after crystallization from dichloromethane/ethyl acetate/diethyl ether, N-(1,5-dihydroxypentan-3-yl)-[2,1,3]-benzoxadiazole-5-carboxamide as a white solid (Mp: 87-88° C.) stirred for 1 h The reaction mixture was evaporated onto silica gel purified by chromatography eluting with ethyl acetate/chloroform (60:40)
ソース ID: ord-5bcd8f5b995649dbbf183835db538685PubChem References
化合物の公開データベース記録に掲載された情報源です。
関連製品
12 related records
CAS 10405-07-9
CAS 1402805-31-5
CAS 116173-94-5
CAS 89282-69-9
CAS 1354350-00-7
CAS 2137539-09-2
CAS 1565989-00-5
CAS 1356090-41-9
CAS 2207524-70-5
CAS 220952-90-9
CAS 1487552-00-0
CAS 4379-15-1
